APP, PSEN1, and PSEN2 Variants in Alzheimer’s Disease: Systematic Re-evaluation According to ACMG Guidelines
The strategies of classifying APP , PSEN1 , and PSEN2 variants varied substantially in the previous studies. We aimed to re-evaluate these variants systematically according to the American college of medical genetics and genomics and the association for molecular pathology (ACMG-AMP) guidelines. In...
Saved in:
Published in | Frontiers in aging neuroscience Vol. 13; p. 695808 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Lausanne
Frontiers Research Foundation
18.06.2021
Frontiers Media S.A |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The strategies of classifying
APP
,
PSEN1
, and
PSEN2
variants varied substantially in the previous studies. We aimed to re-evaluate these variants systematically according to the American college of medical genetics and genomics and the association for molecular pathology (ACMG-AMP) guidelines. In our study,
APP
,
PSEN1
, and
PSEN2
variants were collected by searching Alzforum and PubMed database with keywords “PSEN1,” “PSEN2,” and “APP.” These variants were re-evaluated based on the ACMG-AMP guidelines. We compared the number of pathogenic/likely pathogenic variants of
APP
,
PSEN1
, and
PSEN2
. In total, 66
APP
variants, 323
PSEN1
variants, and 63
PSEN2
variants were re-evaluated in our study. 94.91% of previously reported pathogenic variants were re-classified as pathogenic/likely pathogenic variants, while 5.09% of them were variants of uncertain significance (VUS).
PSEN1
carried the most prevalent pathogenic/likely pathogenic variants, followed by
APP
and
PSEN2
. Significant statistically difference was identified among these three genes when comparing the number of pathogenic/likely pathogenic variants (
P
< 2.2 × 10
–16
). Most of the previously reported pathogenic variants were re-classified as pathogenic/likely pathogenic variants while the others were re-evaluated as VUS, highlighting the importance of interpreting
APP
,
PSEN1
, and
PSEN2
variants with caution according to ACMG-AMP guidelines. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Reviewed by: Francesca Luisa Conforti, University of Calabria, Italy; Diego Castillo-Barnes, University of Granada, Spain Edited by: Nicola Ticozzi, University of Milan, Italy |
ISSN: | 1663-4365 1663-4365 |
DOI: | 10.3389/fnagi.2021.695808 |